Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 3
1964 1
1967 1
1970 2
1971 3
1974 3
1976 1
1977 2
1978 6
1979 1
1980 4
1981 4
1982 8
1983 12
1984 7
1985 10
1986 3
1987 5
1988 6
1989 10
1990 3
1991 7
1992 11
1993 6
1994 11
1995 13
1996 21
1997 30
1998 47
1999 34
2000 49
2001 19
2002 20
2003 22
2004 22
2005 18
2006 19
2007 12
2008 26
2009 19
2010 16
2011 26
2012 23
2013 22
2014 13
2015 20
2016 33
2017 14
2018 17
2019 33
2020 19
2021 30
2022 41
Text availability
Article attribute
Article type
Publication date

Search Results

740 results
Results by year
Filters applied: . Clear all
Page 1
[Development of innovative T-cell immunotherapy for hematological malignancies].
Ochi T. Ochi T. Rinsho Ketsueki. 2019;60(7):824-833. doi: 10.11406/rinketsu.60.824. Rinsho Ketsueki. 2019. PMID: 31391373 Review. Japanese.
With the emergence of cancer immunotherapy, T cells have played important roles in inducing antitumor responses. Many types of antitumor receptors, which possess tumor-binding sites and T-cell activation sites, have been developed. For example, genetically engineere …
With the emergence of cancer immunotherapy, T cells have played important roles in inducing antitumor responses. Many types of antitu …
A single-chain antibody generation system yielding CAR-T cells with superior antitumor function.
Ochi T, Maruta M, Tanimoto K, Kondo F, Yamamoto T, Kurata M, Fujiwara H, Masumoto J, Takenaka K, Yasukawa M. Ochi T, et al. Commun Biol. 2021 Mar 2;4(1):273. doi: 10.1038/s42003-021-01791-1. Commun Biol. 2021. PMID: 33654176 Free PMC article.
Cancer immunotherapy using T cells redirected with chimeric antigen receptor (CAR) has shown a lot of promise. ...Therefore, the optimization of an scFv is needed to maximize the in vivo antitumor functions of CAR-T cells. This system may allow us to adjust an immun …
Cancer immunotherapy using T cells redirected with chimeric antigen receptor (CAR) has shown a lot of promise. ...Therefore, the opti …
Application of adoptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia.
Ochi T, Fujiwara H, Yasukawa M. Ochi T, et al. J Biomed Biotechnol. 2010;2010:521248. doi: 10.1155/2010/521248. Epub 2010 May 5. J Biomed Biotechnol. 2010. PMID: 20454585 Free PMC article. Review.
Beginning with the identification of cancer antigens, followed by the clinical application of anti-cancer peptide vaccination, it has now been proven that adoptive T-cell therapy (ACT) using cancer antigen-specific T cells is the most effective option. ...Currently, …
Beginning with the identification of cancer antigens, followed by the clinical application of anti-cancer peptide vaccination, it has now be …
Perspectives on protein crystallisation.
Ochi T, Bolanos-Garcia VM, Stojanoff V, Moreno A. Ochi T, et al. Prog Biophys Mol Biol. 2009 Nov;101(1-3):56-63. doi: 10.1016/j.pbiomolbio.2009.12.001. Epub 2009 Dec 11. Prog Biophys Mol Biol. 2009. PMID: 20005246 Review.
Novel immunotherapy for adult T-cell leukemia/lymphoma: Targeting aurora kinase A.
Casey NP, Fujiwara H, Ochi T, Yasukawa M. Casey NP, et al. Oncoimmunology. 2016 Oct 7;5(11):e1239006. doi: 10.1080/2162402X.2016.1239006. eCollection 2016. Oncoimmunology. 2016. PMID: 27999761 Free PMC article.
Adult T-cell leukemia/lymphoma is caused by infection with HTLV-1, following a long latent period. Immunotherapy targeting Aurora kinase A, a tumor-associated antigen over-expressed in adult T-cell leukemia/lymphoma, holds great therapeutic potential. We review the …
Adult T-cell leukemia/lymphoma is caused by infection with HTLV-1, following a long latent period. Immunotherapy targeting Aurora kin …
Gene Modification and Immunological Analyses for the Development of Immunotherapy Utilizing T Cells Redirected with Antigen-Specific Receptors.
Ochi T, Maruta M, Hirano N. Ochi T, et al. Methods Mol Biol. 2019;2048:27-39. doi: 10.1007/978-1-4939-9728-2_3. Methods Mol Biol. 2019. PMID: 31396926
To achieve this, it is important to establish the ways (1) to generate optimal viral particle for T-cell transduction, (2) to transduce antitumor receptors into T cells and expand redirected T cells efficiently, and (3) to assess the functionality of antigen- …
To achieve this, it is important to establish the ways (1) to generate optimal viral particle for T-cell transduction, (2) to transdu …
Surgery for pancreatic tumors in the midst of COVID-19 pandemic.
Kato H, Asano Y, Arakawa S, Ito M, Kawabe N, Shimura M, Hayashi C, Ochi T, Yasuoka H, Higashiguchi T, Kondo Y, Nagata H, Horiguchi A. Kato H, et al. World J Clin Cases. 2021 Jun 26;9(18):4460-4466. doi: 10.12998/wjcc.v9.i18.4460. World J Clin Cases. 2021. PMID: 34222414 Free PMC article. Review.
Requisite considerations for successful adoptive immunotherapy with engineered T-lymphocytes using tumor antigen-specific T-cell receptor gene transfer.
Ochi T, Fujiwara H, Yasukawa M. Ochi T, et al. Expert Opin Biol Ther. 2011 Jun;11(6):699-713. doi: 10.1517/14712598.2011.566853. Epub 2011 Mar 18. Expert Opin Biol Ther. 2011. PMID: 21413911 Review.
INTRODUCTION: Although engineered T-cell-based antitumor immunotherapy using tumor-antigen-specific T-cell receptor (TCR) gene transfer is undoubtedly a promising strategy, a number of studies have revealed that it has several drawbacks. ...Readers will be able to r …
INTRODUCTION: Although engineered T-cell-based antitumor immunotherapy using tumor-antigen-specific T-cell receptor (TCR) gene …
740 results